On October 5th, just as the 30-day countdown to the China International Import Expo, the world’s leading biopharmaceutical company Merck China announced that it will go to the fifth session from November 5th to 10th. China International Import Expo (hereinafter referred to as “CIIE”).
Hand-painted design of MSD booth at the 5th CIIE
According to reports, this year coincides with the 30th anniversary of Merck & Co.’s entry into China. At that time, the theme of the exhibition will be “Thirty and ‘Strength’, Bright Future, Healthy and Shared”, and will focus on displaying its more than 100 years of history. The innovative product pipeline, the outstanding achievements in China for 30 years, and the shining journey of sharing the same breath and destiny with China’s medical and health industry, will be through a series of innovative exhibits, interactive experiences and colorful booth activities.
Exhibition at CIIE for four consecutive times
MSD has not only participated in the CIIE for four consecutive years, but also is one of the largest exhibitors, fully demonstrating its long-term commitment to the Chinese market and sharing the opportunities of CIIE.
At this year’s CIIE, Merck’s booth covers an area of 1,000 square meters and is located at 7.2A3-03 of the Medical Equipment and Healthcare Exhibition Area. The main exhibition area is based on the theme of “Thirty and ‘Strength’, Shining the Future”, and is composed of four sub-sections of “Medicine Road”, “Key Road”, “Key Road” and “Yao Road”, showing MSD in an all-round way. Continue to strengthen the product portfolio of cutting-edge “drugs” and vaccines to create efficient disease prevention and treatment solutions; strengthen excellent and efficient operations through digitalization, and strengthen important “important” local innovation and cooperation; practice corporate social responsibility and create sustainable The “key” of patient access; give full play to the advantages of R&D, manufacturing and commercial operations in one, “dazzle” to move the future, and the beautiful vision of walking with China and sharing health.
The star product of oral anti-coronavirus drugs will be unveiled at the CIIE
Merck’s star product in development – the oral anti-coronavirus drug monoprevir (at press time, the drug has not been approved in China) – will also appear at this year’s CIIE meeting. Recently, Merck and China National Pharmaceutical Group Co., Ltd. (“Sinopharm Group”) jointly announced the signing of a cooperation framework agreement. Merck will grant the distribution rights and exclusive import rights of monoravir jointly developed by it and Ridgeback to Sinopharm Group; Sinopharm Group Sinopharm Group Co., Ltd. After obtaining the technology transfer of Monoravir from Merck, it will actively promote localized production and supply. This move once again highlights Merck’s commitment to continue to contribute to the fight against the new crown epidemic by strengthening local cooperation.
Anna Van Acker, President of MSD China and MSD Global Senior Vice President, said: “MSD is an active participant in the CIIE. We have been together for five years and we have witnessed China becoming more open and more open. Emphasizing cooperation has also made our footsteps in China more determined. This year, Merck China, who is thirty and ‘powerful’, has stepped into a key ‘life’ node – in his 30th year, he has made achievements and has more vigorous innovation. , towards a more vibrant future.
MSD said that China has always been a vital part of Merck’s global growth strategy. For more than 130 years, Merck has always adhered to the value of “drugs are produced for human beings, not for the pursuit of profit”, and is committed to bringing high-quality drugs and vaccines to Chinese patients and the public as soon as possible; Vaccines, to a powerful prevention and treatment system that saves the lives of patients with cardiovascular and metabolic diseases, infectious diseases and tumors; to help the high-quality development of China’s medical and health services, and to move towards “people’s health as the center”.
【Reporter】Li Jie
【Author】 Li Jie
Healthy Life Circle